These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19188395)
1. High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Ostergaard C; Sandvang D; Frimodt-Møller N; Kristensen HH Antimicrob Agents Chemother; 2009 Apr; 53(4):1581-5. PubMed ID: 19188395 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Xiong YQ; Hady WA; Deslandes A; Rey A; Fraisse L; Kristensen HH; Yeaman MR; Bayer AS Antimicrob Agents Chemother; 2011 Nov; 55(11):5325-30. PubMed ID: 21859940 [TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Andes D; Craig W; Nielsen LA; Kristensen HH Antimicrob Agents Chemother; 2009 Jul; 53(7):3003-9. PubMed ID: 19414576 [TBL] [Abstract][Full Text] [Related]
5. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. McCracken GH; Sakata Y Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342 [TBL] [Abstract][Full Text] [Related]
12. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis. Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033 [TBL] [Abstract][Full Text] [Related]
13. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871 [TBL] [Abstract][Full Text] [Related]
14. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968 [TBL] [Abstract][Full Text] [Related]
15. Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin. Gerber J; Smirnov A; Wellmer A; Ragheb J; Prange J; Schütz E; Wettich K; Kalich S; Nau R Antimicrob Agents Chemother; 2001 Jul; 45(7):2169-72. PubMed ID: 11408247 [TBL] [Abstract][Full Text] [Related]
16. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696 [TBL] [Abstract][Full Text] [Related]
17. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454 [TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits. Takahata M; Yamada H; Morita T; Furubou S; Minami S; Todo Y; Watanabe Y; Narita H Antimicrob Agents Chemother; 2002 Jun; 46(6):1760-5. PubMed ID: 12019087 [TBL] [Abstract][Full Text] [Related]